Stay updated on Combination Immunotherapy for Prostate Cancer Clinical Trial

Sign up to get notified when there's something new on the Combination Immunotherapy for Prostate Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Combination Immunotherapy for Prostate Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    A site-wide NIH announcement banner was added with transition updates and a notice about federal agencies’ terminology for artificial intelligence. The study record remains inaccessible behind a 403 error.
    Difference
    1%
    Check dated 2026-10-25T15:17:59.000Z thumbnail image
  2. Check
    11 days ago
    Change Detected
    Summary
    The footer’s site revision number changed from v3.7.1 to v3.7.2.
    Difference
    0.2%
    Check dated 2026-10-18T15:19:57.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    The site footer revision changes from **v3.7.0** to **v3.7.1** while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-11T15:09:44.000Z thumbnail image
  4. Check
    39 days ago
    Change Detected
    Summary
    The page now returns a 403 Forbidden error, replacing the study record content with a generic error page. This blocks access to the study details and related information on the page.
    Difference
    24%
    Check dated 2026-09-20T14:01:07.000Z thumbnail image
  5. Check
    60 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.5 to v3.6.6, indicating a new release of the page template or site revision. This change affects only the revision label and does not modify study data or user-facing content.
    Difference
    0.0%
    Check dated 2026-08-29T23:57:46.000Z thumbnail image
  6. Check
    75 days ago
    Change Detected
    Summary
    New documents and IPD sharing details were added to the study record, including the Informed Consent Form, Study Protocol and SAP, and the IPD Sharing Plan with access criteria and time frame. It also references the NIH Clinical Center and NCI personnel, providing context on the study's governance and transparency.
    Difference
    91%
    Check dated 2026-08-15T23:33:02.000Z thumbnail image

Stay in the know with updates to Combination Immunotherapy for Prostate Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Combination Immunotherapy for Prostate Cancer Clinical Trial page.